WRLD A.LIVE

03:005 reports

• CervoMed publishes two peer-reviewed studies on DLB drug neflamapimod StreetInsider
• CervoMed publishes phase 2b trial results for DLB treatment Investing.com
• Phase 2b trial of neflamapimod in dementia with Lewy bodies fails to replicate earlier promise Bioengineer.org
• CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB) Yahoo Finance
• Neflamapimod for Dementia With Lewy Bodies Misses End Point, Subgroup Signal Emerges Psychiatric Times

02:00nothing heard

01:004 reports

• AviadoBio Presents New Preclinical Data Validating the vMiX Platform for AVB-406 in Alzheimer’s Disease and for AVB-SNCA in Parkinson’s Disease at ESGCT 2026 FirstWord Pharma
• Alzheimer’s Blood Tests Need Clearer Primary Care Guidance, AdvaMed Panelists Say Medtech Insight
• New blood test can detect changes associated with Alzheimer’s disease NPR
• Large genetic study uncovers new risk factors for Alzheimer's News-Medical

00:002 reports

• Alzheimer’s Treatments Bring New Hope And Urgency To Early Diagnosis Forbes
• Alzheimer’s Treatments Bring New Hope And Urgency To Early Diagnosis Yahoo Health